**Chapter 6**

*Vectors and Vector-Borne Zoonotic Diseases*

Molecular and Cellular Biology. Jun.

immunostimulatory potential in vivo. Frontiers in Microbiology. 2015;**6**:1-19

[63] Jain K, Jain NK. Novel therapeutic strategies for treatment of visceral leishmaniasis. Drug Discovery Today.

[62] de Souza A et al. Promising nanotherapy in treating leishmaniasis. International Journal of Pharmaceutics.

2018;**547**(1-2):421-431

2013;**18**(23-24):1272-1281

[55] Mohapatra S. Drug resistance in leishmaniasis: Newer developments. Tropical Parasitology. 2014;**4**(1):4

Leishmaniainfantum as a novel wholecell vaccine for visceral leishmaniasis. Clinical and Vaccine Immunology.

[56] Bruhn KW et al. Killed but metabolically active

[57] Da Silva ER, Maquiaveli C d C, Magalhães PP. The

Experimental Parasitology. 2012;**130**(3):183-188

leishmanicidalflavonolsquercetin and quercitrin target Leishmania (Leishmania) amazonensisarginase.

[58] Thakur CP et al. Anti-leishmanial activity of Agave Americana L.–A traditional Indian medicinal plant. Indian Journal of Traditional Knowledge. 2015;**14**(4):658-663

[59] Carneiro SMP, Carvalho FAA, Santana LCLR, Sousa APL, Neto JMM, Chaves MH. The cytotoxic and antileishmanial activity of extracts and fractions of leaves and fruits of Azadirachtaindica (aJuss.). Biological

Research. 2012;**45**(2):111-116

[60] Khanna VG, Kannabiran K, Getti G. Leishmanicidal activity of saponins isolated from the leaves of Ecliptaprostrata and

Gymnemasylvestre. Indian Journal of Pharmacology. 2009;**41**(1):32-35

[61] Chouhan G et al. Leishmanicidal activity of Piper nigrum bioactive fractions is interceded via apoptosis in vitro and substantiated by Th1

2012;**19**(4):490-498

[54] Tanwar J, Das S, Fatima Z, Hameed S. Multidrug resistance: An emerging crisis. Interdisciplinary Perspectives on Infectious Diseases.

1992;**12**(6):2855-2865

2014;**2014**:541340

**86**
